Two O
alternatively O
spliced O
VHL B
mRNAs O
characterized O
by O
inclusion O
( O
isoform O
I O
) O
or O
exclusion O
( O
isoform O
II O
) O
of O
exon O
2 O
are O
transcribed O
in O
adult O
tissues O
. O

Gene O
therapy O
for O
phenylketonuria B
. O

We O
report O
in O
this O
work O
the O
molecular O
bases O
of O
C7D B
in O
two O
unrelated O
Japanese O
males O
. O

Low O
incidence O
of O
BRCA2 O
mutations O
in O
breast B
carcinoma I
and O
other O
cancers B
. O

The O
DM B
region O
of O
chromosome O
19 O
is O
gene O
rich O
, O
and O
it O
is O
possible O
that O
the O
repeat O
expansion O
may O
lead O
to O
dysfunction O
of O
a O
number O
of O
transcription O
units O
in O
the O
vicinity O
, O
perhaps O
as O
a O
consequence O
of O
chromatin O
disruption O
. O

Prostate B
cancer I
is O
the O
second O
leading O
cause O
of O
male O
cancer B
deaths O
in O
the O
United O
States O
. O

Individuals O
who O
have O
rare O
alleles O
of O
the O
VNTR O
have O
an O
increased O
risk O
of O
certain O
types O
of O
cancers B
, O
including O
breast B
cancer I
( O
2 O
- O
4 O
) O
. O

A O
cell O
line O
has O
been O
established O
from O
the O
tumour B
of O
the O
proband O
and O
cytogenetic O
and O
molecular O
studies O
carried O
out O
, O
providing O
an O
extensive O
analysis O
in O
this O
family O
. O
. O

Chromosome O
3p O
deletion O
was O
detected O
in O
98 O
per O
cent O
of O
non B
- I
papillary I
renal I
cell I
carcinomas I
and O
in O
25 O
per O
cent O
of O
chromophobe O
renal B
cell I
carcinomas I
. O

Atm O
- O
null O
mice O
, O
as O
well O
as O
those O
null O
for O
p53 O
, O
develop O
mainly O
T B
- I
cell I
lymphomas I
, O
supporting O
the O
view O
that O
these O
genes O
have O
similar O
roles O
in O
thymocyte O
development O
. O

2 O
, O
a O
region O
proposed O
to O
contain O
tumor B
suppressor O
gene O
( O
s O
) O
, O
is O
mutated O
at O
high O
frequency O
in O
human O
breast B
cancer I
. O

Mutation O
analysis O
of O
BRCA1 O
and O
BRCA2 O
in O
a O
male B
breast I
cancer I
population O
. O

To O
evaluate O
this O
prevalence O
, O
we O
performed O
biochemical O
analysis O
of O
very O
long O
chain O
fatty O
acids O
in O
14 O
male O
patients O
( O
age O
ranging O
from O
12 O
- O
45 O
yr O
at O
diagnosis O
) O
previously O
diagnosed O
as O
having O
primary O
idiopathic O
adrenocortical B
insufficiency I
. O

We O
tentatively O
isolate O
three O
different O
types O
of O
SJS B
type I
1A I
, O
usually O
recognized O
in O
childhood O
, O
with O
moderate O
bone B
dysplasia I
, O
corresponding O
to O
the O
original O
descriptions O
of O
Schwartz O
, O
Jampel O
and O
Aberfeld O
; O
type O
1B O
, O
similar O
to O
type O
1A O
but O
recognizable O
at O
birth O
, O
with O
more O
pronounced O
bone B
dysplasia I
resembling O
Kniest B
dysplasia I
; O
and O
type O
2 O
, O
manifest O
at O
birth O
, O
with O
increased O
mortality O
and O
bone B
dysplasia I
resembling O
Pyle B
disease I
. O

